ALI’s second-quarter revenues skyrocket

Article

ALI Technologies, of Richmond, British Columbia, continues to reap the rewards of a healthy PACS market. The ultrasound miniPACS developer posted revenues of $3.1 million (Canadian) for the second quarter of fiscal 1997 (end-March 31), a 92% increase

ALI Technologies, of Richmond, British Columbia, continues to reap the rewards of a healthy PACS market. The ultrasound miniPACS developer posted revenues of $3.1 million (Canadian) for the second quarter of fiscal 1997 (end-March 31), a 92% increase over the $1.6 million reported in the same period in 1996. Net income was $457,000 versus $6000 netted in the 1996 fiscal second quarter.

ALI celebrated several accomplishments in the second quarter, highlighted by the announcement that GE Medical Systems would purchase up to 19.9% of ALI's outstanding equity (SCAN 4/2/97). Negotiation over final documentation of the deal is ongoing, according to the company.

Other notable achievements in the second quarter included the first shipments of the UltraPACS 3.0 upgrade as well as the vendor's SWS 250 notebook PC-based sonographers' workstation. The company installed nine UltraPACS systems in the second quarter, seven of which were in North America.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.